Brian Man1, Chendi Cui1, Xiao Zhang1, Daisuke Sugiyama1,2, Emma Barinas-Mitchell1, Akira Sekikawa3. 1. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 130 North Bellefield Avenue, Pittsburgh, PA, 15213, USA. 2. Faculty of Nursing and Medical Care, Keio University, 4411 Endo, Fujisawa, Kanagawa, 252-0883, Japan. 3. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 130 North Bellefield Avenue, Pittsburgh, PA, 15213, USA. akira@pitt.edu.
Abstract
PURPOSE: Some but not all randomized controlled trials (RCTs) of soy isoflavones showed their beneficial effect on arterial stiffness, a predictor of cardiovascular events, dementia, and all-cause mortality, independent of traditional risk factors. To test the hypothesis that supplementation of soy isoflavones reduces arterial stiffness, we performed a systematic review and meta-analysis of RCTs of soy isoflavones on arterial stiffness. METHODS: The protocol of this systematic review was registered with PROSPERO (CRD42019126128) and written in accordance with PRISMA. The PubMed, Embase, and clinicaltrials.gov databases were searched using the following criteria: human subjects, soy isoflavones as intervention, and arterial stiffness as primary outcome. A random-effects meta-analysis was used to pool estimates across studies. Standardized mean difference (SMD) was used to synthesize quantitative results. RESULTS: Among 998 articles retrieved, 8 articles met our criteria. Duration of intervention was relatively short (maximum of 12 weeks). Outcome measurements extracted were pulse wave velocity (PWV), systemic arterial compliance (SAC), augmentation index (AI), and cardio-ankle vascular index (CAVI). Soy isoflavones reduced arterial stiffness compared to placebo (standardized mean difference - 0.33, 95% confidence interval - 0.47, - 0.19). Subgroup analyses showed no difference between treatment effects for intervention duration (< 6 weeks vs. ≥ 6 weeks) or gender (women only vs. men only vs. combined). Sensitivity analysis showed no difference in the effect of soy isoflavones between PWV, CAVI, SAC, and AI. CONCLUSION: Supplementation of soy isoflavones reduced arterial stiffness. Longer duration trials with larger number of participants are warranted.
PURPOSE: Some but not all randomized controlled trials (RCTs) of soy isoflavones showed their beneficial effect on arterial stiffness, a predictor of cardiovascular events, dementia, and all-cause mortality, independent of traditional risk factors. To test the hypothesis that supplementation of soy isoflavones reduces arterial stiffness, we performed a systematic review and meta-analysis of RCTs of soy isoflavones on arterial stiffness. METHODS: The protocol of this systematic review was registered with PROSPERO (CRD42019126128) and written in accordance with PRISMA. The PubMed, Embase, and clinicaltrials.gov databases were searched using the following criteria: human subjects, soy isoflavones as intervention, and arterial stiffness as primary outcome. A random-effects meta-analysis was used to pool estimates across studies. Standardized mean difference (SMD) was used to synthesize quantitative results. RESULTS: Among 998 articles retrieved, 8 articles met our criteria. Duration of intervention was relatively short (maximum of 12 weeks). Outcome measurements extracted were pulse wave velocity (PWV), systemic arterial compliance (SAC), augmentation index (AI), and cardio-ankle vascular index (CAVI). Soy isoflavones reduced arterial stiffness compared to placebo (standardized mean difference - 0.33, 95% confidence interval - 0.47, - 0.19). Subgroup analyses showed no difference between treatment effects for intervention duration (< 6 weeks vs. ≥ 6 weeks) or gender (women only vs. men only vs. combined). Sensitivity analysis showed no difference in the effect of soy isoflavones between PWV, CAVI, SAC, and AI. CONCLUSION: Supplementation of soy isoflavones reduced arterial stiffness. Longer duration trials with larger number of participants are warranted.
Authors: Tracy A Ryan-Borchers; Jean Soon Park; Boon P Chew; Michelle K McGuire; Lisa R Fournier; Kathy A Beerman Journal: Am J Clin Nutr Date: 2006-05 Impact factor: 7.045
Authors: H Wiseman; J D O'Reilly; H Adlercreutz; A I Mallet; E A Bowey; I R Rowland; T A Sanders Journal: Am J Clin Nutr Date: 2000-08 Impact factor: 7.045
Authors: Chendi Cui; Akira Sekikawa; Lewis H Kuller; Oscar L Lopez; Anne B Newman; Allison L Kuipers; Rachel H Mackey Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Kunihiro Matsushita; Ning Ding; Esther D Kim; Matthew Budoff; Julio A Chirinos; Bo Fernhall; Naomi M Hamburg; Kazuomi Kario; Toru Miyoshi; Hirofumi Tanaka; Raymond Townsend Journal: J Clin Hypertens (Greenwich) Date: 2018-11-19 Impact factor: 3.738
Authors: Xiao Zhang; Cole V Veliky; Rahel L Birru; Emma Barinas-Mitchell; Jared W Magnani; Akira Sekikawa Journal: Nutrients Date: 2021-10-23 Impact factor: 5.717
Authors: Akira Sekikawa; Aya Higashiyama; Brian J Lopresti; Masafumi Ihara; Howard Aizenstein; Makoto Watanabe; Yuefang Chang; Chikage Kakuta; Zheming Yu; Chester Mathis; Yoshihioro Kokubo; William Klunk; Oscar L Lopez; Lewis H Kuller; Yoshihiro Miyamoto; Chendi Cui Journal: Alzheimers Dement (N Y) Date: 2020-10-22